GC1118 in Recurrent Glioblastoma Patients With High EGFR Amplification
Clinical trial NCT03618667 · COMPLETED
Trial details
- NCT number
- NCT03618667
- Sponsor
- Samsung Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-22
- Primary completion
- 2018-09-08
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.